SCHEMBL4655320

SCHEMBL4655320

CC(C)Oc1ccc(Oc2nc3ccc(CC=O)cc3s2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.39
LMNA P02545 2/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
ALOX12 P18054 1/20 0.39
HTT P42858 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
LTA4H P09960 8/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KCNH2 Q12809 3/20 0.38
EPHX2 P34913 2/20 0.37
MAPK1 P28482 1/20 0.37
PIK3CD O00329 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4654087 0.84 SMN1; SMN2 (0.49) MAPTHTTLTA4HCYP1A2CYP3A4
SCHEMBL4505988 0.77 SMN1; SMN2 (0.50) POLBLMNAMEN1ALDH1A1MAPT
SCHEMBL4519178 0.76 SMN1; SMN2 (0.40) POLBLMNAMEN1ALDH1A1MAPT
SCHEMBL4689887 0.76 CYP1A2 (0.60) LTA4HCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL3726328 0.76 ACACB (0.40) POLBCYP1A2CYP3A4MAPK1ALDH1A3
SCHEMBL3720760 0.75 ALDH1A3 (0.45) POLBKMT2ACYP1A2CYP2D6CYP2C19
SCHEMBL11013933 0.74 PPARA (0.41) LMNAMEN1ALDH1A1MAPTHPGD
SCHEMBL4516981 0.74 SMN1; SMN2 (0.37) POLBLMNAMEN1ALDH1A1MAPT
SCHEMBL3719825 0.74 ALDH1A1 (0.45) LMNAMEN1ALDH1A1MAPTHPGD
SCHEMBL2622449 0.74 SMN1; SMN2 (0.37) POLBLMNAMEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1996567-A2 NOVEL ACETYL-COA CARBOXYLASE (ACC) INHIBITORS AND THEIR USE IN DIABETES, OBESITY AND METABOLIC SYNDROME ABBOTT LABORATORIES (US) 2008-12-03 EP disclosed
WO-2007095601-A2 NOVEL ACETYL-COA CARBOXYLASE (ACC) INHIBITORS AND THEIR USE IN DIABETES, OBESITY AND METABOLIC SYNDROME ABBOTT LABORATORIES (US) 2007-08-23 WO disclosed